Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    21903021 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Double Blind, Placebo-controlled Study of Raloxifene for Negative Symptoms of Schizophrenia in Postmenopausal Women
Condition: Schizophrenia
Intervention: Drug: raloxifene

Indicates status has not been verified in more than two years